Research and Development

The Research and Development team at Palatin Technologies focuses on the discovery and optimization of innovative therapeutics that target the melanocortin peptide receptor system. Comprising experts in drug characterization, bioinformatics, and various scientific disciplines, the team conducts cutting-edge research to advance novel biopharmaceutical candidates from concept through preclinical development, ensuring efficacy, safety, and potential for leading-edge patient treatments.